Medicare Enrolled
Dr. Omid Shaye, M.D.
Hematology & Oncology · West Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shaye from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shaye?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shaye
Dr. Omid Shaye is a hematology & oncology specialist in West Hills, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shaye performed 72,724 Medicare services across 5,491 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shaye received a total of $6,680 from 69 pharmaceutical and/or device companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shaye is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 10% volume in CA
$6,680 industry payments
Medicare Practice Summary
Medicare Utilization ↗72,724
Medicare services
Top 10% in CA for hematology & oncology
5,491
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,040 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
18,870 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 14,839 | $43 | $107 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
7,872 | $36 | $91 |
| Denosumab injection (Prolia/Xgeva) | 4,387 | $18 | $46 |
| Anti-nausea injection (ondansetron/Zofran) | 3,056 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,037 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,485 | $8 | $15 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
2,036 | $9 | $19 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,971 | $107 | $283 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,776 | $10 | $21 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
1,454 | $5 | $10 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,263 | $6 | $6 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
1,015 | $7 | $13 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
746 | $19 | $38 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
744 | $27 | $70 |
| Iron level test | 560 | $6 | $13 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
556 | $9 | $17 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
555 | $13 | $27 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 534 | $20 | $42 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
505 | $123 | $324 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
500 | $13 | $32 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
411 | $2 | $5 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
321 | $102 | $219 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
302 | $60 | $159 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
265 | $16 | $32 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
247 | $19 | $48 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
215 | $0 | $2 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
202 | $16 | $34 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
200 | $14 | $29 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
196 | $156 | $399 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
186 | $77 | $201 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
182 | $26 | $68 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
179 | $15 | $30 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
155 | $28 | $59 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
148 | $61 | $157 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
124 | $148 | $424 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
114 | $5 | $16 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
87 | $1 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $144 | $369 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
67 | $68 | $152 |
| New patient office visit, complex (60-74 min) | 58 | $187 | $487 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
58 | $1 | $4 |
| PSA test (prostate cancer screening) | 56 | $18 | $37 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
53 | $14 | $36 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
47 | $25 | $52 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $12 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
39.4% high complexity
36.7% medium
23.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,680
Total received (2018-2024)
Avg $954/year across 7 years
Top 38% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
253
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,487 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$192 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,245
2023
$1,740
2022
$1,151
2021
$739
2020
$404
2019
$854
2018
$547
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$161
Astellas Pharma US Inc
$122
AstraZeneca Pharmaceuticals LP
$109
EMD Serono, Inc.
$79
Ardelyx, Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$68
AIMMUNE THERAPEUTICS, INC.
$66
Genentech USA, Inc.
$64
ADC Therapeutics America, Inc.
$63
Eisai Inc.
$61
Incyte Corporation
$54
PharmaEssentia USA Corporation
$49
Immunocore Limited
$35
SpringWorks Therapeutics, Inc.
$33
PFIZER INC.
$29
Agios Pharmaceuticals, Inc.
$28
E.R. Squibb & Sons, L.L.C.
$27
Novartis Pharmaceuticals Corporation
$23
SOBI, INC
$23
Meridian Bioscience Inc.
$22
Janssen Biotech, Inc.
$22
Aveo Pharmaceuticals, Inc.
$21
Gilead Sciences, Inc.
$15
Top 3 companies account for 31.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$472
PFIZER INC.
$402
Janssen Biotech, Inc.
$343
Regeneron Healthcare Solutions, Inc.
$324
Seagen Inc.
$299
AstraZeneca Pharmaceuticals LP
$282
Astellas Pharma US Inc
$251
Novartis Pharmaceuticals Corporation
$228
ADC Therapeutics America, Inc.
$214
Karyopharm Therapeutics Inc.
$208
Lilly USA, LLC
$193
GENZYME CORPORATION
$193
Incyte Corporation
$162
Romark Laboratories, LC
$159
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$142
Genentech USA, Inc.
$138
Gilead Sciences, Inc.
$138
Celgene Corporation
$124
Aurobindo Pharma USA, Inc.
$124
PORTOLA PHARMACEUTICALS, INC.
$122
Amgen Inc.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$110
EMD Serono, Inc.
$104
Ardelyx, Inc.
$104
AIMMUNE THERAPEUTICS, INC.
$98
Bayer HealthCare Pharmaceuticals Inc.
$86
Dendreon Pharmaceuticals LLC
$84
Eisai Inc.
$78
Seattle Genetics, Inc.
$77
Merck Sharp & Dohme LLC
$76
Octapharma USA, Inc.
$69
Foundation Medicine, Inc.
$59
Boston Scientific Corporation
$57
JAZZ PHARMACEUTICALS INC.
$49
PharmaEssentia USA Corporation
$49
Daiichi Sankyo Inc.
$48
Medtronic, Inc.
$47
TOLMAR Pharmaceuticals, Inc.
$47
Janssen Pharmaceuticals, Inc
$45
Acceleron Pharma, Inc.
$44
Merck Sharp & Dohme Corporation
$37
AVEO Pharmaceuticals, Inc.
$36
Immunocore Limited
$35
SpringWorks Therapeutics, Inc.
$33
Organon LLC
$30
GlaxoSmithKline, LLC.
$29
TAIHO ONCOLOGY, INC.
$29
ImmunoGen, Inc.
$29
Blueprint Medicines Corporation
$29
Agios Pharmaceuticals, Inc.
$28
Puma Biotechnology, Inc.
$25
AMAG Pharmaceuticals, Inc.
$24
G1 Therapeutics, Inc.
$23
Ironwood Pharmaceuticals, Inc
$23
Helsinn Therapeutics (U.S.), Inc.
$23
CSL Behring
$23
SOBI, INC
$23
Meridian Bioscience Inc.
$22
CTI BioPharma Corp.
$22
Aveo Pharmaceuticals, Inc.
$21
Synergy Pharmaceuticals Inc
$21
MAYNE PHARMA INC.
$21
AbbVie Inc.
$20
Mirati Therapeutics, Inc.
$20
Coherus Biosciences Inc.
$20
Lantheus Medical Imaging, Inc.
$19
Braintree Laboratories, Inc.
$18
TESARO, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Top 3 companies account for 18.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · ANDEXXA · Alinia · Alinia Tablets 500mg 30 count bottle · BAVENCIO · BESREMI · BOSULIF · Beleodaq · CALQUENCE · COSELA · CYRAMZA · DARZALEX · DUPIXENT · Definity · ELELYSO · ELIGARD · ELIQUIS · ELITEK · ENHERTU · ERLEADA · EXKIVITY · Elahere · Enhertu · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAVRETO · GI GENIUS · Hizentra · IBRANCE · IBSRELA · IMBRUVICA · INLYTA · Inrebic · JAKAFI · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LINZESS · LONSURF · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · MONJUVI · MOTOFEN · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · ONTRUZANT · OPDIVO · PANZYGA · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pomalyst · REBLOZYL · Reblozyl · SARCLISA · SCEMBLIX · STELARA · Stivarga · TAGRISSO · TALZENNA · TECENTRIQ · TECVAYLI · TRULANCE · TUKYSA · Tecentriq · Trodelvy · Trulance · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOWST · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
251
Per 100K population
2.5
County median income
$87,760
Nearest hospital
UCLA WEST VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shaye is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shaye experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Shaye performed 18,870 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shaye receive payments from pharmaceutical companies?
Yes. Dr. Shaye received a total of $6,680 from 69 companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shaye's costs compare to other hematology & oncology specialists in West Hills?
Dr. Shaye's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shaye) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in West Hills
Browse hematology & oncology specialists in West Hills ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology